Craig Rennie (Independent Non executive Director)
Craig Rennie ( 59 ) has worked in the international pharmaceutical industry for over 30 years, initially in increasingly senior sales and marketing positions with Beechams in the UK and subsequently in international management posts with the Wellcome Foundation.
After a successful sales and marketing career with Beechams, and subsequently in international management posts with the Wellcome Foundation.
After almost 20 years based overseas, Craig returned to the UK in 1995 and, having established his own company, was subsequently appointed Chief Executive and President of a newly established, US venture backed biotechnology company. In January 1999 Craig was appointed Chief Executive of Penn Pharmaceuticals where he led a primary MBO in 2000 and a secondary MBO and refinancing in 2004, when he assumed the role of Chairman and Chief Executive. Having sold part of the company for £64 million in 2004 Craig sold the remaining business in April 2007 for £67 million thereby achieving an 18 fold increase in valuation in six and a half years.
On 19 March 2008 Craig was appointed as Chairman of the Remuneration Committee and became a member of the Audit Committee.
